MoneyWorks4Me

Zydus Lifesciences - Quaterly Results

03 Feb 2023 Evaluate
The revenue zoomed 14.02% to Rs. 20869.00 millions for the quarter ended December 2022 as compared to Rs. 18303.00 millions during the corresponding quarter last year.The company has announced a 29.90% increase in its profits to Rs . 2559.00  millions for the  quarter ended December 2022 compared to Rs. 1970.00 millions in the corresponding quarter in the previous year.OP of the company witnessed a marginal growth to 5949.00 millions from 3845.00 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 20869.00 18303.00 14.02 64666.00 59626.00 8.45 79819.00 77800.00 2.60
Other Income 1363.00 259.00 426.25 2972.00 1250.00 137.76 1787.00 893.00 100.11
PBIDT 5949.00 3845.00 54.72 19791.00 15855.00 24.82 20968.00 23980.00 -12.56
Interest 885.00 246.00 259.76 1932.00 929.00 107.97 1349.00 709.00 90.27
PBDT 5064.00 3599.00 40.71 17859.00 11733.00 52.21 16426.00 21396.00 -23.23
Depreciation 1216.00 1200.00 1.33 3687.00 3559.00 3.60 4787.00 4511.00 6.12
PBT 3848.00 2399.00 60.40 14172.00 8174.00 73.38 11639.00 16885.00 -31.07
TAX 1289.00 429.00 200.47 3787.00 2064.00 83.48 3060.00 2123.00 44.14
Deferred Tax 427.00 183.00 133.33 465.00 241.00 92.95 458.00 -910.00 -150.33
PAT 2559.00 1970.00 29.90 10385.00 6110.00 69.97 8579.00 14762.00 -41.88
Equity 1012.00 1024.00 -1.17 1024.00 1024.00 0.00 1024.00 1024.00 0.00
PBIDTM(%) 28.51 21.01 35.70 30.60 26.59 15.10 26.27 30.82 -14.77
Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1242.00
Cipla 1331.00
Lupin 1953.75
Zydus Lifesciences 1113.00
View more..